Evidence map›Paper›PMID 40990501›Full record

ArticleInternational journal of surgery (London, England)2026

Global, regional, and national burden of tuberculosis, 1990-2050: a systematic comparative analysis based on retrospective cross-sectional of GBD 2021 and WHO surveillance systems.

Fan Jiang, Xuemei Li, Qing Qiao, Mingming Zhang, Yuan Tian, Shuang Zhou, Yufeng Li, Ruizi Ni, Yajing An, Yanhua Liu and 2 more

Abstract readComparative Study
In one paragraph

Article in International journal of surgery (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Fan JiangSenior Department of Tuberculosis, Chinese PLA General Hospital, Beijing, China.
Xuemei LiRespiratory Medicine Department, The Fourth People's Hospital of Jinan, Jinan, Shandong, China.
Qing QiaoRespiratory Medicine Department, The Fourth People's Hospital of Jinan, Jinan, Shandong, China.
Mingming ZhangSenior Department of Tuberculosis, Chinese PLA General Hospital, Beijing, China.
Yuan TianSenior Department of Tuberculosis, Chinese PLA General Hospital, Beijing, China.
Shuang ZhouSenior Department of Tuberculosis, Chinese PLA General Hospital, Beijing, China.
Yufeng LiSenior Department of Tuberculosis, Chinese PLA General Hospital, Beijing, China.
Ruizi NiSenior Department of Tuberculosis, Chinese PLA General Hospital, Beijing, China.
Yajing AnSenior Department of Tuberculosis, Chinese PLA General Hospital, Beijing, China.
Yanhua LiuSenior Department of Tuberculosis, Chinese PLA General Hospital, Beijing, China.
Lingxia ZhangSenior Department of Tuberculosis, Chinese PLA General Hospital, Beijing, China.
Wenping GongSenior Department of Tuberculosis, Chinese PLA General Hospital, Beijing, China.ORCID 0000-0002-0333-890

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTuberculosis (TB) persists as a leading global health threat. Current surveillance is fragmented, and the surgical burden of drug-resistant forms remains poorly quantified.

methodsUsing GBD 2021 (1990-2050) and WHO-GHO (2000-2021), we estimated mortality, incidence, prevalence, and disability-adjusted life years (DALYs) for 204 countries by age, sex, and four TB subtypes: latent tuberculosis infection (LTBI), drug-susceptible tuberculosis (DS-TB), multidrug-resistant tuberculosis (MDR-TB), and extensively drug-resistant tuberculosis (XDR-TB). We compared WHO and GBD figures in eight high-burden countries, applied joinpoint regression to project trends, and quantified risk-factor contributions.

resultsIn 2021, global TB rates per 100,000 were: prevalence 236.14 (95% UI 214.51-260.20), incidence 103.00 (92.21-114.91), deaths 13.96 (12.61-15.72), and DALYs 580.26 (522.37-649.82). Sociodemographic index (SDI) gradients were steepest for XDR-TB. Smoking, high alcohol use and elevated fasting glucose explained >0.1% of DS-TB DALYs each. WHO-GBD mortality diverged in Bangladesh, Nigeria, and the Democratic Republic of the Congo; incidence differed markedly in Indonesia and the Philippines. Projections indicate rising mortality after 2030 in Indonesia and the Western Pacific under high-risk scenarios.

conclusionsXDR-TB is emerging as the fastest-growing threat. Discrepancies between WHO and GBD compromise resource allocation; harmonisation is urgently needed, especially for surgical services planning in Indonesia and the Western Pacific.

Indexed as

TuberculosisAdolescentAdultChildChild, PreschoolCross-Sectional StudiesDisability-Adjusted Life YearsFemaleGlobal Burden of DiseaseGlobal HealthHumansIncidenceMaleMiddle AgedPrevalenceRetrospective Studiesdrug resistance states (DRS)global burden of disease (GBD)high-burden countries (hBCs)socio-demographic index (SDI)tuberculosis (TB)

Identifiers

PMID40990501
PMCPMC12825930

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.